Logixboard Raises $32M Series B from Insight Partners to Continue Modernizing the $2T Freight Forwarding Industry January 26, 2022
Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platform January 25, 2022
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Hong Kong Market for the Treatment of Adults With Locally Advanced Or Metastatic Cholangiocarcinoma With A FGFR2 Fusion Or Rearrangement That Have Progressed After At Least One Prior Line Of Systemic Therapy January 24, 2022
Loans Canada and Even Financial Announce Strategic Partnership to Help Canadian Borrowers January 20, 2022
Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2 Clinical Trial of XTX202 for the Treatment of Patients with Solid Tumors January 20, 2022
CENTOGENE Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Target Discovery, Applying Artificial Intelligence (AI) to Accelerate Orphan Drug Development January 20, 2022
WellAir Announces Strategic Partnership with the Association for Professionals in Infection Control and Epidemiology (APIC) January 20, 2022